Abstract:Abstract Background: Hypoxia inducible factor-1α (HIF-1α) is a therapeutic target in solid tumors because it activates transcription of the genes associated with tumor growth, angiogenesis and chemo/radio-resistance. Activation of PPARα has been demonstrated to inhibit tumor growth and angiogenesis, yet the mechanisms behind these actions remain obscure. The present study examined the effects of PPARα activation on HIF-1α mediated signaling in human cancer cells. Methods: The human cancer lines MCF-7 (breast) and A2780 (ovarian), and human endothelial line, EA.hy926 were used as model systems for this study. Hypoxia was achieved via a hypoxia chamber. The HRE-luciferase reporter gene and Western blot were applied to analyze HIF-1α expression and activity. RT-PCR and co-immunoprecipitation were performed to understand the molecular mechanisms of PPARα-mediated suppression of HIF-1α signaling. The level of vascular endothelial growth factor (VEGF) in cultured medium was determined using an ELISA, and in vitro angiogenesis was evaluated using the tube formation assay. Results: Incubation of cancer cells with 1 % oxygen for 16 hours significantly induced HIF-1α expression and activity. Treatment of the cells with PPARα agonists, but not a PPARγ agonist, prior to hypoxia diminished hypoxia-induced HIF-1α expression and activity. Consistently, a PPARα antagonist attenuated PPARα agonist-induced suppression of HIF-1α signaling. Over-expression of an HA-tagged HIF-1α and HIF-1α-P402/P564A mutant protein demonstrated that activation of PPARα promotes HIF-1 α degradation in our model system. This was further confirmed by the use of MG-132, a proteasome inhibitor, which reversed PPARα-mediated suppression of the HIF-1α signaling, and by RT-PCR analysis of HIF-1α mRNA, which was unchanged by PPARα activation. Using the co-immunoprecipitation technique, we found that activation of PPARα enhances the binding of hydroxylated HIF-1α to the Von Hippel-Lindau tumor suppressor, a protein known to mediate HIF-1α degradation through the ubiquitin-proteasome pathway. Consequential to the PPARα-mediated suppression of HIF-1α signaling, vascular endothelial growth factor secretion from cancer cells was found to be significantly reduced, and the tube formation by EA.hy926 cells was dramatically impaired. Summary: Activation of PPARα suppresses HIF-1α expression and activity by promoting HIF-1α degradation in cancer cells. PPARα agonists are potential anticancer agents that inhibit tumor angiogenesis via the suppression of HIF-1α signaling. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2011 Nov 12-16; San Francisco, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2011;10(11 Suppl):Abstract nr B7.

CCAAT/enhancer-binding Protein Α Antagonizes Transcriptional Activity of Hypoxia-Inducible Factor 1 Α with Direct Protein–protein Interaction

Hypoxia Regulates the Expression and Localization of CCAAT/enhancer Binding Protein Α by Hypoxia Inducible Factor-1Α in Bladder Transitional Carcinoma Cells

Identification of Cathepsin B As a Novel Target of Hypoxia-Inducible Factor-1-alpha in HepG2 Cells.

Upregulation of C/EBPα Contributes to Colorectal Cancer Growth, Metastasis and Indicates Poor Survival Outcome.

Physical and Functional Interactions of Acute Myeloid Leukemia-1 with Hypoxia Inducible Factor-1α Protein.

Eif4e Binding Protein 1 Expression is Associated with Clinical Survival Outcomes in Colorectal Cancer

Proteomics-based identification of two novel direct targets of hypoxia-inducible factor-1 and their potential roles in migration/invasion of cancer cells.

The Biological Effects of C/EBPα in K562 Cells Depend on the Potency of the N-terminal Regulatory Region, Not on Specificity of the DNA Binding Domain

Hif-1 Alpha And Taz Serve As Reciprocal Co-Activators In Human Breast Cancer Cells

CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation–induced cell death in hepatocellular carcinoma

Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer

Hypoxia-inducible Factor-1Α-induced Differentiation of Myeloid Leukemic Cells is Its Transcriptional Activity Independent

C/Ebp Alpha And Hnf6 Protein Complex Formation Stimulates Hnf6-Dependent Transcription By Cbp Coactivator Recruitment In Hepg2 Cells

Repression of Transcription Mediated by Dual Elements in the CCAAT/enhancer Binding Protein Α Gene

C/EBPβ Promotes the Viability of Human Bladder Cancer Cell by Contributing to the Transcription of Bladder Cancer Specific Lncrna UCA1.

Abstract B7: Activation of PPARα Suppresses HIF-1α Signaling in Human Cancer Cells.

C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes

C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting Β-Catenin

Cypa, A Gene Downstream Of Hif-1 Alpha, Promotes The Development Of Pdac

Transcription Factor EHF Interacting with Coactivator AJUBA Aggravates Malignancy and Acts As a Therapeutic Target for Gastroesophageal Adenocarcinoma

EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1 alpha pathway